Oligonucleotide Therapeutics Society

Scientist position

July 15th, 2026|

About Cora Biosciences We are a newly launched, venture-backed biotech spinout from a leading academic institution, dedicated to transforming the treatment of serious diseases using next-generation antisense oligonucleotide (ASO) therapeutics. With a strong scientific foundation and a leadership team of experienced drug developers, we are ...

Go to Top